000311831 000__ 01594cam\a22004094a\4500 000311831 001__ 311831 000311831 005__ 20210513113807.0 000311831 008__ 060125s2006\\\\nyu\\\\\\b\\\\001\0deng\\ 000311831 010__ $$a 2006002543 000311831 020__ $$a0521683831 (pbk.) 000311831 020__ $$a9780521683838 (pbk.) 000311831 020__ $$a0521864550 000311831 020__ $$a9780521864558 000311831 035__ $$a(OCoLC)ocm63179037 000311831 035__ $$a311831 000311831 040__ $$aDLC$$cDLC$$dYDXCP$$dUKM$$dBAKER$$dCOO$$dIG#$$dOCLCQ$$dBTCTA$$dYUS$$dUWC 000311831 042__ $$apcc 000311831 043__ $$an-us--- 000311831 049__ $$aISEA 000311831 05000 $$aHD9666.9.M4$$bV34 2006 000311831 08200 $$a338.7/616151092$$aB$$222 000311831 1001_ $$aVagelos, P. Roy. 000311831 24514 $$aThe moral corporation--Merck experiences /$$cP. Roy Vagelos, Louis Galambos. 000311831 260__ $$aNew York :$$bCambridge University Press,$$c2006. 000311831 300__ $$aix, 185 p. ;$$c23 cm. 000311831 500__ $$aIncludes index. 000311831 504__ $$aIncludes bibliographical references and index. 000311831 5050_ $$aThe puzzle -- The professional path -- Turn around -- New drugs and public safety -- Corporate grooming -- Winning in global competition -- Prices and the public interest -- Moral leadership -- Afterwards. 000311831 60010 $$aVagelos, P. Roy. 000311831 61020 $$aMerck & Co.$$xManagement. 000311831 650_0 $$aPharmaceutical industry$$xMoral and ethical aspects$$zUnited States. 000311831 650_0 $$aBusiness ethics. 000311831 650_0 $$aSocial responsibility of business. 000311831 7001_ $$aGalambos, Louis. 000311831 85200 $$bgen$$hHD9666.9.M4$$iV34$$i2006 000311831 85641 $$3Table of contents$$uhttp://www.loc.gov/catdir/toc/ecip067/2006002543.html 000311831 85642 $$3Publisher description$$uhttp://www.loc.gov/catdir/enhancements/fy0633/2006002543-d.html 000311831 909CO $$ooai:library.usi.edu:311831$$pGLOBAL_SET 000311831 980__ $$aBIB 000311831 980__ $$aBOOK 000311831 994__ $$aC0$$bISE